𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast

✍ Scribed by Anna M. Bofin; Stian Lydersen; Bjørn M. Hagmar

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
237 KB
Volume
31
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aberrant expression of muc1 mucin in duc
Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast
✍ Ellen C.M. Mommers; Angelique M. Leonhart; Silvia von Mensdorff-Pouilly; Dick J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 2 views

MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought

Ductal carcinoma in situ of the male bre
Ductal carcinoma in situ of the male breast
✍ Mauricio G. Camus; Megha G. Joshi; Gasan Mackarem; Arthur K. C. Lee; Ricardo L. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr

Heterogeneity of ductal carcinoma in sit
Heterogeneity of ductal carcinoma in situ of the breast
✍ Michael D. Lagios 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents